dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Castelo-Branco, L. |
dc.contributor.author | Awada, Ahmad |
dc.contributor.author | Pentheroudakis, G. |
dc.contributor.author | Perez-Gracia, J. L. |
dc.contributor.author | Mateo Valderrama, Joaquim |
dc.contributor.author | Curigliano, Giuseppe |
dc.contributor.author | Tabernero Caturla, Josep |
dc.date.accessioned | 2022-04-22T12:58:05Z |
dc.date.available | 2022-04-22T12:58:05Z |
dc.date.issued | 2021-10 |
dc.identifier.citation | Castelo-Branco L, Awada A, Pentheroudakis G, Perez-Gracia JL, Mateo J, Curigliano G, et al. Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology. ESMO Open. 2021 Oct;6(5):100237. |
dc.identifier.issn | 2059-7029 |
dc.identifier.uri | https://hdl.handle.net/11351/7372 |
dc.description | Pandèmia de COVID-19; Oncologia |
dc.description.sponsorship | None declared. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | ESMO Open;6(5) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Oncologia |
dc.subject | Pandèmia de COVID-19, 2020- |
dc.subject | Assaigs clínics |
dc.subject.mesh | Coronavirus Infections |
dc.subject.mesh | Medical Oncology |
dc.subject.mesh | Clinical Trial |
dc.title | Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.esmoop.2021.100237 |
dc.subject.decs | infecciones por Coronavirus |
dc.subject.decs | oncología médica |
dc.subject.decs | ensayo clínico |
dc.relation.publishversion | https://doi.org/10.1016/j.esmoop.2021.100237 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Castelo-Branco L, Pentheroudakis G] Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland. [Awada A] Head of the Oncology Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Belgium. [Perez-Gracia JL] Department of Oncology, Clinica Universidad de Navarra, Pamplona, Spain. [Mateo J] Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Curigliano G] Istituto Europeo di Oncologia, IRCCS and University of Milano, Milano, Italy. [Tabernero J] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, Barcelona, Spain |
dc.identifier.pmid | 34411971 |
dc.identifier.wos | 000704803800035 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |